KARISA SON: Open Payments
NPI 1780064212 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,115 in 138 payments from 17 companies in 2025. Trend: 2023 $2,400 · 2024 $2,299 · 2025 $3,115
Food & beverage: $2,805Education: $310
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $442 |
| Regeneron Healthcare Solutions, Inc. | 13 | $422 |
| Galderma Laboratories, L.P. | 14 | $409 |
| ABBVIE INC. | 19 | $373 |
| UCB, Inc. | 12 | $253 |
| PFIZER INC. | 16 | $243 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $199 |
| Lilly USA, LLC | 6 | $151 |
| LEO Pharma Inc. | 8 | $141 |
| Incyte Corporation | 5 | $110 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, Bimzelx, RINVOQ, CIBINQO, SKYRIZI, TALTZ.
Industry payments across NV — which companies pay providers there.
